The Institutional Biosafety Committee (IBC) reviews all research involving recombinant and biohazardous material that is performed at or sponsored by the University of Arizona, or for entities that have a contract with the University of Arizona.
Protocol Amendments
Approvals Holders (AHs) must submit changes to any IBC-approved protocol and receive approval prior to commencing any new work. Download, complete, and submit the Amendment Form to ehs-help@arizona.edu.
New Protocols
To obtain IBC approval for research involving recombinant and/or biohazardous material, the Approval Holder must download, complete, and submit the following to ehs-help@arizona.edu.
The IBC is charged with ensuring experiments are evaluated and designed to minimize laboratory acquired infections of recombinant and biohazardous material. The Committee makes recommendations or imposes requirements when necessary to modify experimental procedures to reduce the possibility of inadvertent generation of aerosols.
The IBC is comprised of University faculty and staff and two representatives from the community. Members are selected based on their expertise, ensuring that the Committee has the collective experience to evaluate the risks associated with the use of recombinant and biohazardous material in a wide variety of research proposals. Members of the IBC must recuse themselves from voting on projects in which they are or expect to be engaged in, or have a direct financial interest. Non-committee faculty or staff with special expertise will be asked to advise the Committee when the need arises.
IBC meetings are held the third Wednesday of each month, and are open to the public. All forms must be submitted to EHS (ehs-help@arizona.edu) by the second Wednesday of the month for review and addition to that months agenda.